About Virginia Pierce, MD

Dr. Virginia Pierce received her medical degree from Washington University School of Medicine in St. Louis in 2005. She then completed residency training and a chief residency in pediatrics at Yale-New Haven Hospital, followed by fellowships in pediatric infectious diseases at the Children’s Hospital of Philadelphia and medical microbiology at Massachusetts General Hospital.

Dr. Pierce joined the Massachusetts General Hospital Pathology faculty in 2014, and serves as Associate Director of the Massachusetts General Hospital Clinical Microbiology Laboratories. She also serves as an attending physician on the MassGeneral Hospital for Children Pediatric Infectious Disease service and as the Associate Director of the Medical Microbiology Fellowship Program.

Clinical Interests:



MassGeneral Hospital for Children: Pediatric Infectious Disease & Immunodeficiencies Program
275 Cambridge St.
Suite 101
Boston, MA 02114
Phone: 617-724-8990

Mass General Pathology
55 Fruit St.
Boston, MA 02114
Phone: 617-643-0800

Medical Education

  • MD, Washington University School of Medicine in St. Louis
  • Residency, Yale New Haven Hospital
  • Fellowship, Children's Hospital of Philadelphia
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Medical Microbiology, American Board of Pathology
  • Pediatric Infectious Diseases, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research Interests of Virginia M. Pierce, MD

  • Development, evaluation, and application of antimicrobial susceptibility testing methods in the clinical microbiology laboratory
  • Development, evaluation, and application of new testing strategies in clinical microbiology
  • Improvement of existing diagnostic approaches and algorithms in clinical microbiology

Clinical Research Affiliations


  • Selected Publications

    • Shenoy ES*, Pierce VM*, Walters MS, et al.  Transmission of mobile colistin resistance (mcr-1) by duodenoscope.  Clin Infect Dis 2018; Sep 11. doi: 10.1093/cid/ciy683.*contributed equally to this work
    • Tamma PD, Pierce VM, Cosgrove SE, et al.  Can the ceftriaxone breakpoint be increased without compromising patient outcomes?  Open Forum Infect Dis. 2018 Jun 8;5(6):ofy139. doi: 10.1093/ofid/ofy139.
    • Pierce VM, Simner PJ, Lonsway DR, et al.  Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae.  J Clin Microbiol 2017; 55: 2321-33.

Reviews: Comments and Ratings